SCHEMBL7220547

SCHEMBL7220547

CCCCC(=O)c1ccncc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 8/20 0.63
HTR7 P34969 1/20 0.61
HDAC3 O15379 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC2 Q92769 1/20 0.53
NAAA Q02083 1/20 0.53
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2D6 P10635 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
ALPI P09923 1/20 0.50
PLOD2 O00469 1/20 0.50
PLOD3 O60568 1/20 0.50
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
PLOD1 Q02809 1/20 0.50
HIF1A Q16665 1/20 0.50
STS P08842 1/20 0.50
GAA P10253 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3983005 0.94 HSD17B3 (0.65) HSD17B3HTR7HDAC3HDAC1HDAC2
SCHEMBL9146061 0.92 HSD17B3 (0.66) HSD17B3HTR7NAAASTSHRH2
SCHEMBL29959715 0.92 HSD17B3 (0.66) HSD17B3HTR7NAAASTSHRH2
SCHEMBL11267484 0.92 HSD17B3 (0.66) HSD17B3HTR7NAAASTSHRH2
SCHEMBL9440245 0.92 HSD17B3 (0.66) HSD17B3HTR7NAAASTSHRH2
Propyl 4-Pyridyl Ketone SCHEMBL4952700 0.88 HSD17B3 (0.61) HSD17B3HTR7HDAC3HDAC1HDAC2
SCHEMBL14522305 0.85 HSD17B3 (0.83) HSD17B3HTR7HPGDSTSNPC1
SCHEMBL15988710 0.83 CYP2C19 (0.61) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL11391741 0.82 PLOD2 (0.48) HSD17B3HTR7CYP1A2CYP3A4CYP2D6
SCHEMBL28647965 0.81 KMT2A (0.56) HSD17B3HTR7CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6509361-B1 Inhibit the activity of p38 MAP kinase. Also contemplated by the invention are processes for the preparation of the contemplated compounds and for the use of a contemplated compound in treating a mammalian host having a p38 kinase or PHARMACIA CORPORATION 2003-01-21 US disclosed
EP-1077971-A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2001-02-28 EP disclosed
WO-1999058523-A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 1999-11-18 WO disclosed
US-5023334-A Anthelmintic pyridinyl acylhydrazones THE UPJOHN COMPANY (US) 1991-06-11 US disclosed
US-5011932-A Anthelmintic pyridinyl acylhydrazones derivatives UPJOHN COMPANY (US) 1991-04-30 US disclosed
EP-0214158-A1 ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS THE UPJOHN COMPANY (US) 1987-03-18 EP disclosed
WO-1986004582-A1 ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS THE UPJOHN COMPANY (US) 1986-08-14 WO disclosed
EP-0046446-A1 Polyazaheterocyclic compounds, process for their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1982-02-24 EP disclosed